New 52 Week Low Today

First Wave BioPharma Inc FWBI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:52 PM EST
1.37quote price arrow down-0.06 (-4.20%)
Volume
11,338
Close
1.43quote price arrow down-0.15 (-9.49%)
Volume
690,477
52 week range
1.35 - 26.30
Loading...
  • Open1.51
  • Day High1.56
  • Day Low1.35
  • Prev Close1.58
  • 52 Week High26.30
  • 52 Week High Date01/22/21
  • 52 Week Low1.35
  • 52 Week Low Date12/03/21

Key Stats

  • Market Cap14.26M
  • Shares Out9.97M
  • 10 Day Average Volume0.54M
  • Dividend-
  • Dividend Yield-
  • Beta1.75
  • YTD % Change-85.26

KEY STATS

  • Open1.51
  • Day High1.56
  • Day Low1.35
  • Prev Close1.58
  • 52 Week High26.30
  • 52 Week High Date01/22/21
  • 52 Week Low1.35
  • 52 Week Low Date12/03/21
  • Market Cap14.26M
  • Shares Out9.97M
  • 10 Day Average Volume0.54M
  • Dividend-
  • Dividend Yield-
  • Beta1.75
  • YTD % Change-85.26

RATIOS/PROFITABILITY

  • EPS (TTM)-16.36
  • P/E (TTM)-0.09
  • Fwd P/E (NTM)-0.49
  • EBITDA (TTM)-38.04M
  • ROE (TTM)-2,387.58%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)1.98%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On First Wave BioPharma Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
First Wave BioPharma, Inc., formerly AzurRx BioPharma, Inc., is a clinical-stage biopharmaceutical company. It is engaged in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. It is focused on advancing a therapeutic development pipeline built around its two technologies: niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic adrulipase, a recombinant lipase enzyme designed to enable the...
James Sapirstein
Chairman
Daniel Schneiderman
Chief Financial Officer
Address
777 Yamato Road, Suite 502
Boca Raton, FL
33431
United States

Top Peers

SYMBOLLASTCHG%CHG
TRVI
Trevi Therapeutics Inc
0.8982-0.0518-5.4526%
HOTH
Hoth Therapeutics Inc
0.745-0.0608-7.5453%
PSTV
Plus Therapeutics Inc
1.22-0.19-13.48%
PHIO
Phio Pharmaceuticals Corp
1.18-0.06-4.84%
KPRX
Kiora Pharmaceuticals Inc
1.25-0.14-10.07%